Why the study?
Does transcatheter radiofrequency ablation improve acute success and prevent recurrence of VT in patients with ischemic heart disease and drug-refractory VT?
Population
21 selected patients with ischemic heart disease and recurrent, drug-refractory VT documented by 12-lead…
Design
Cohort
Follow-up
mean 13.2 +/- 5.0 months
Authors
Loading...
High recurrence despite acute success should not yet change practice; leaves open efficacy in randomized trials for ischemic VT.
Does transcatheter radiofrequency ablation improve acute success and prevent recurrence of VT in patients with ischemic heart disease and drug-refractory VT?
Transcatheter RF ablation for drug-refractory VT in ischemic heart disease is feasible and acutely successful in most patients, but long-term recurrence is high, often requiring additional antiarrhythmic therapy.
Kim et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: